Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Yves Dietrich

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Blood|August 29, 2009
Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error?Pierre-Yves Dietrich
CNS Oncology|July 24, 2014
Injecting hope into brain cancer treatment: is immunotherapy the way forward?Pierre-Yves Dietrich
Praxis|March 1, 2023
Cancer Immunotherapy: One Century to Shift from a Crazy Hypothesis to Daily PracticePierre-Yves Dietrich
The Lancet. Oncology|September 22, 2011
Prevention of CNS relapse in diffuse large B-cell lymphomaRobert Kridel, Pierre-Yves Dietrich
Revue Medicale Suisse|February 20, 2020
Solange Peters, Pierre-Yves Dietrich
Medecine Sciences : M/S|May 2, 2020
[Therapeutic vaccination for glioblastoma]Pierre-Yves Dietrich, Valérie Dutoit
Revue Medicale Suisse|June 11, 2016
[Immunotherapy for brain tumors: obstacles and perspectives]Denis Migliorini, Pierre-Yves Dietrich
Revue Medicale Suisse|March 15, 2018
Francesco Bianchi-Demicheli, Pierre-Yves Dietrich
Current Opinion in Oncology|August 13, 2019
Current strategies for vaccination in glioblastomaValérie Dutoit, Denis Migliorini, Pierre-Yves Dietrich
Revue Medicale Suisse|May 17, 2018
Solange Peters, Pierre-Yves Dietrich, Matti Aapro
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Blood|August 29, 2009
Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error?Pierre-Yves Dietrich
CNS Oncology|July 24, 2014
Injecting hope into brain cancer treatment: is immunotherapy the way forward?Pierre-Yves Dietrich
Praxis|March 1, 2023
Cancer Immunotherapy: One Century to Shift from a Crazy Hypothesis to Daily PracticePierre-Yves Dietrich
The Lancet. Oncology|September 22, 2011
Prevention of CNS relapse in diffuse large B-cell lymphomaRobert Kridel, Pierre-Yves Dietrich
Revue Medicale Suisse|February 20, 2020
Solange Peters, Pierre-Yves Dietrich
Medecine Sciences : M/S|May 2, 2020
[Therapeutic vaccination for glioblastoma]Pierre-Yves Dietrich, Valérie Dutoit
Revue Medicale Suisse|June 11, 2016
[Immunotherapy for brain tumors: obstacles and perspectives]Denis Migliorini, Pierre-Yves Dietrich
Revue Medicale Suisse|March 15, 2018
Francesco Bianchi-Demicheli, Pierre-Yves Dietrich
Current Opinion in Oncology|August 13, 2019
Current strategies for vaccination in glioblastomaValérie Dutoit, Denis Migliorini, Pierre-Yves Dietrich
Revue Medicale Suisse|May 17, 2018
Solange Peters, Pierre-Yves Dietrich, Matti Aapro
Pageof 18